187 related articles for article (PubMed ID: 18828767)
1. Transplant acceptance following anti-CD4 versus anti-CD40L therapy: evidence for differential maintenance of graft-reactive T cells.
Wood SC; Lu G; Burrell BE; Bishop DK
Am J Transplant; 2008 Oct; 8(10):2037-48. PubMed ID: 18828767
[TBL] [Abstract][Full Text] [Related]
2. The immunobiology of inductive anti-CD40L therapy in transplantation: allograft acceptance is not dependent upon the deletion of graft-reactive T cells.
Nathan MJ; Yin D; Eichwald EJ; Bishop DK
Am J Transplant; 2002 Apr; 2(4):323-32. PubMed ID: 12118853
[TBL] [Abstract][Full Text] [Related]
3. Blockade of CD40 ligand-CD40 interaction impairs CD4+ T cell-mediated alloreactivity by inhibiting mature donor T cell expansion and function after bone marrow transplantation.
Blazar BR; Taylor PA; Panoskaltsis-Mortari A; Buhlman J; Xu J; Flavell RA; Korngold R; Noelle R; Vallera DA
J Immunol; 1997 Jan; 158(1):29-39. PubMed ID: 8977172
[TBL] [Abstract][Full Text] [Related]
4. Immunobiology of allograft rejection in the absence of IFN-gamma: CD8+ effector cells develop independently of CD4+ cells and CD40-CD40 ligand interactions.
Bishop DK; Chan Wood S; Eichwald EJ; Orosz CG
J Immunol; 2001 Mar; 166(5):3248-55. PubMed ID: 11207279
[TBL] [Abstract][Full Text] [Related]
5. Murine Fibroblastic Reticular Cells From Lymph Node Interact With CD4+ T Cells Through CD40-CD40L.
Nakayama Y; Brinkman CC; Bromberg JS
Transplantation; 2015 Aug; 99(8):1561-7. PubMed ID: 25856408
[TBL] [Abstract][Full Text] [Related]
6. Host CD40 ligand deficiency induces long-term allograft survival and donor-specific tolerance in mouse cardiac transplantation but does not prevent graft arteriosclerosis.
Shimizu K; Schönbeck U; Mach F; Libby P; Mitchell RN
J Immunol; 2000 Sep; 165(6):3506-18. PubMed ID: 10975872
[TBL] [Abstract][Full Text] [Related]
7. Blockade of the CD40-CD40 ligand pathway potentiates the capacity of donor-derived dendritic cell progenitors to induce long-term cardiac allograft survival.
Lu L; Li W; Fu F; Chambers FG; Qian S; Fung JJ; Thomson AW
Transplantation; 1997 Dec; 64(12):1808-15. PubMed ID: 9422424
[TBL] [Abstract][Full Text] [Related]
8. OX40 costimulation prevents allograft acceptance induced by CD40-CD40L blockade.
Burrell BE; Lu G; Li XC; Bishop DK
J Immunol; 2009 Jan; 182(1):379-90. PubMed ID: 19109169
[TBL] [Abstract][Full Text] [Related]
9. Analysis of the CD40 and CD28 pathways on alloimmune responses by CD4+ T cells in vivo.
Bingaman AW; Ha J; Durham MM; Waitze SY; Tucker-Burden C; Cowan SR; Pearson TC; Larsen CP
Transplantation; 2001 Oct; 72(7):1286-92. PubMed ID: 11602857
[TBL] [Abstract][Full Text] [Related]
10. Aggressive skin allograft rejection in CD28-/- mice independent of the CD40/CD40L costimulatory pathway.
Ha J; Bingaman AW; Durham MM; Pearson TC; Larsen CP
Transpl Immunol; 2001 Oct; 9(1):13-7. PubMed ID: 11680567
[TBL] [Abstract][Full Text] [Related]
11. Anti-OX40L monoclonal antibody prolongs secondary heart allograft survival based on CD40/CD40L and LFA-1/ICAM-1 blockade.
Dai H; Peng F; Lin M; Xia J; Yu S; Lan G; Wang Y; Xie X; Fang C; Corbascio M; Qi Z; Peng L
Transpl Immunol; 2015 Mar; 32(2):84-91. PubMed ID: 25613092
[TBL] [Abstract][Full Text] [Related]
12. Increased apoptosis of immunoreactive host cells and augmented donor leukocyte chimerism, not sustained inhibition of B7 molecule expression are associated with prolonged cardiac allograft survival in mice preconditioned with immature donor dendritic cells plus anti-CD40L mAb.
Lu L; Li W; Zhong C; Qian S; Fung JJ; Thomson AW; Starzl TE
Transplantation; 1999 Sep; 68(6):747-57. PubMed ID: 10515374
[TBL] [Abstract][Full Text] [Related]
13. In vivo helper functions of alloreactive memory CD4+ T cells remain intact despite donor-specific transfusion and anti-CD40 ligand therapy.
Chen Y; Heeger PS; Valujskikh A
J Immunol; 2004 May; 172(9):5456-66. PubMed ID: 15100287
[TBL] [Abstract][Full Text] [Related]
14. NK cells are required for costimulatory blockade induced tolerance to vascularized allografts.
van der Touw W; Burrell B; Lal G; Bromberg JS
Transplantation; 2012 Sep; 94(6):575-84. PubMed ID: 22914174
[TBL] [Abstract][Full Text] [Related]
15. CD4+ T lymphocytes expressing CD40 ligand help the IgM antibody response to soluble pneumococcal polysaccharides via an intermediate cell type.
Jeurissen A; Billiau AD; Moens L; Shengqiao L; Landuyt W; Wuyts G; Boon L; Waer M; Ceuppens JL; Bossuyt X
J Immunol; 2006 Jan; 176(1):529-36. PubMed ID: 16365447
[TBL] [Abstract][Full Text] [Related]
16. 4-1BB promotes long-term survival in skin allografts treated with anti-CD45RB and anti-CD40L monoclonal antibodies.
Lee J; Lee EN; Kim EY; Lee HJ; Park HJ; Sun CL; Lee SK; Joh JW; Lee KW; Kwon GY; Kim SJ
Transplant Proc; 2005; 37(1):123-5. PubMed ID: 15808569
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of early peripheral CD4 T-cell tolerance induction by anti-CD154 monoclonal antibody and allogeneic bone marrow transplantation: evidence for anergy and deletion but not regulatory cells.
Kurtz J; Shaffer J; Lie A; Anosova N; Benichou G; Sykes M
Blood; 2004 Jun; 103(11):4336-43. PubMed ID: 14962909
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms involved in the establishment of tolerance through costimulatory blockade and BMT: lack of requirement for CD40L-mediated signaling for tolerance or deletion of donor-reactive CD4+ cells.
Kurtz J; Ito H; Wekerle T; Shaffer J; Sykes M
Am J Transplant; 2001 Nov; 1(4):339-49. PubMed ID: 12099378
[TBL] [Abstract][Full Text] [Related]
19. Unusual patterns of alloimmunity evoked by allogeneic liver parenchymal cells.
Bumgardner GL; Orosz CG
Immunol Rev; 2000 Apr; 174():260-79. PubMed ID: 10807522
[TBL] [Abstract][Full Text] [Related]
20. Xenoreactive CD4+ memory T cells resist inhibition by anti-CD44 mAb and reject islet grafts via a Th2-dependent pathway.
Peng Y; Chen J; Shao W; Wang F; Dai H; Cheng P; Xia J; Wang F; Huang R; Zhu Q; Qi Z
Xenotransplantation; 2011; 18(4):252-61. PubMed ID: 21848543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
